StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
INBSINTELLIGENT BIO SOLUTIONS INC.
stockpulse.co.kr
Nasdaq
$1.59▼ 1.55%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.8MShares out 2.4M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

20
  • 1d agoAfter-hours26.10.24 05:30
    PRE 14AOther#●●●#●●●

    INTELLIGENT BIO SOLUTIONS INC.

    Intelligent Bio Solutions Inc. will hold its annual meeting on December 3, 2026, to vote on director elections, auditor ratification, amendments to the 2019 Long Term Incentive Plan, and the issuance of up to 2,036,659 shares of common stock upon the exercise of Series N-2 Warrants issued on September 2, 2026. The meeting seeks shareholder approval to comply with Nasdaq Listing Rule 5635(d), with voting rights granted to shareholders of record as of October 13, 2026.…more

    $1.59-1.55%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 3d agoAfter-hours26.10.22 06:00
    10-K/AEarnings

    INTELLIGENT BIO SOLUTIONS INC.

    Intelligent Bio Solutions Inc. filed an amendment (Form 10-K/A) to its 2026 Annual Report to revise executive compensation disclosures, clarify capital raising transactions involving major shareholders, and update the exhibit index. There are no changes to the financial statements, and the company reported 3,027,470 shares of common stock issued and outstanding as of August 18, 2026.…more

    $1.59-1.55%vs prev close
    View filingShare
  • 10.13After-hours26.10.14 06:00
    8-KKey event

    INTELLIGENT BIO SOLUTIONS INC.

    Intelligent Bio Solutions Inc. amended its Bylaws on October 12, 2026, to revise the voting procedures for stockholder meetings. The amendment clarifies that matters other than the election of directors will be decided by a majority of the votes cast, explicitly excluding abstentions and broker non-votes.…more

    $1.59-1.55%vs prev close
    View filingShare

19 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.15After-hours26.09.16 06:04
    Bullish#●●●#●●●

    Intelligent Bio Solutions Registers 6.2M Shares for Warrant Exercise

    Intelligent Bio Solutions has registered over 6.2 million shares of common stock for resale, which are issuable upon the exercise of warrants from a private placement. This registration indicates potential share dilution, which may negatively impact the stock price.…more

    $1.59-1.55%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.10Pre-market26.09.10 21:30

    ●●●●●●●● ●●●●● ●●●●●●

    Intelligent Bio Solutions will host a virtual fireside chat to discuss its FDA 510(k) submission, clinical data, and international commercial progress. Management will provide updates on the regulatory process and the company's business outlook during the live session.…more

    $1.59-1.55%vs prev close
    Read sourceShareGlobeNewswire
  • 9.9Pre-market26.09.09 21:31

    ●●●●●●●● ●●●●● ●●●●●●

    Intelligent Bio Solutions has submitted a 510(k) premarket notification to the FDA for its fingerprint-based drug screening system. This filing leverages extensive clinical data as the company aims to expand its commercial presence in the U.S. market.…more

    $1.59-1.55%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →